Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma.

Disease markers - 1 Jan 2021

Zhang Heng, Ju Qiang, Ji Jing, Zhao Yanjie

Abstract excerpt

Fumarate hydratase (FH) is an important enzymatic component in the tricarboxylic acid cycle. Studies have reported that FH plays an important role in hereditary leiomyomatosis and renal cell cancer (HLRCC). However, the role of FH in human different cancers remains unknown. This study is aimed at analyzing the prognostic value of FH and demonstrating the correlation between FH expression and tumor immunity....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to A549 Cells
Share to Adenocarcinoma of Lung
Share to Biomarkers, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Computational Biology

Share to Fumarate Hydratase

Share to Lymphocytes, Tumor-Infiltrating

Share to Survival Analysis

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34737838
DOI: 10.1155/2021/8554844
PMCID: PMC8563123

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pan-Cancer Analysis Reveals FH as a Potential Prognostic and Immunological Biomarker in Lung Adenocarcinoma.PMID 34737838Read ↗

Genomic Characteristics and Single-Cell Profiles After Immunotherapy in Fumarate Hydratase-Deficient Renal Cell CarcinomaSemantic proximity Read ↗

Four and a half LIM domain protein 1 as a Novel Prognostic Biomarker and Correlation with Immune Infiltration Levels in Lung AdenocarcinomaSemantic proximity Read ↗

Integrated Molecular Characterization of Fumarate Hydratase-deficient Renal Cell Carcinoma.Semantic proximity Read ↗

ALKBH1-8 and FTO: Potential Therapeutic Targets and Prognostic Biomarkers in Lung Adenocarcinoma PathogenesisSemantic proximity Read ↗

Pan-cancer analysis of BLM as a prognostic and immunological marker in human tumorsSemantic proximity Read ↗

Leukocyte CH25H is a potential diagnostic and prognostic marker for lung adenocarcinomaSemantic proximity Read ↗

COL22A1 and DNAH8 mutations are associated with tumor mutation burden and prognosis of lung adenocarcinoma patientsSemantic proximity Read ↗

Evaluation of clinical value and potential mechanism of MTFR2 in lung adenocarcinoma via bioinformaticsSemantic proximity Read ↗

Identification of m6A-Regulated Ferroptosis Biomarkers for Prognosis in Laryngeal CancerSemantic proximity Read ↗

Radical nephrectomy and regional lymph node dissection for locally advanced type 2 papillary renal cell carcinoma in an at-risk individual from a family with hereditary leiomyomatosis and renal cell cancer: a case report.Semantic proximity Read ↗

Prognostic Significance and Immunological Role of FBXO5 in Human Cancers: A Systematic Pan-Cancer AnalysisSemantic proximity Read ↗

Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarkerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.